Pharmacologic treatment of schizoaffective disorder
- 1 May 1994
- journal article
- review article
- Published by Springer Nature in Psychopharmacology
- Vol. 114 (4) , 529-538
- https://doi.org/10.1007/bf02244982
Abstract
No abstract availableKeywords
This publication has 74 references indexed in Scilit:
- The effect of long‐term lithium treatment on the mortality of patients with manic‐depressive and schizoaffective illness*Acta Psychiatrica Scandinavica, 1992
- Morbidity Risks of Schizophrenia and Affective Disorders among First-Degree Relatives of Patients with Schizoaffective DisordersThe British Journal of Psychiatry, 1991
- Unipolar and bipolar schizoaffective disorders: A comparative studyArchiv Fur Psychiatrie Und Nervenkrankheiten, 1989
- A retrospective study on the long-term efficacy of clozapine in 96 schizophrenic and schizoaffective patients during a 13-year periodPsychopharmacology, 1989
- Increased serotonin2 (5-HT2) receptor binding as measured by 3H-lysergic acid diethylamide (3H-LSD) in the blood platelets of depressed patientsLife Sciences, 1989
- Brain 5-HT2 receptor binding sites in depressed suicide victimsBrain Research, 1988
- Serotonin 5-HT2 receptor binding on blood platelets - a peripheral marker for depression?Life Sciences, 1987
- Different effects of serotonin antagonists on 3H-mianserin and 3H-ketanserin recognition sitesLife Sciences, 1985
- Neurotransmitter receptors and monoamine metabolites in the brains of patients with Alzheimer-type dementia and depression, and suicidesNeuropharmacology, 1984
- Psychosis in Bipolar and Unipolar Affective Illness with Special Reference to Schizo-affective DisorderThe British Journal of Psychiatry, 1984